Laura Scelsi

Also affiliated with University Hospital Foundation, Policlinico San Matteo Fondazione, Istituti di Ricovero e Cura a Carattere Scientifico

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial”.

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2025)10.1016/s0140-6736(25)01665-4

N/A

1.3DataRank · unranked

71 citations

Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more

Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2

Pulmonary Circulation(2018)10.1177/2045894018782664

N/A

0.493DataRank · unranked

7 citations

Sara Plumitallo, Laura Scelsi, Giannantonio Maggi, Matteo Sobrero, Annalisa Turco +10 more

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

Genetics in Medicine(2023)10.1016/j.gim.2023.100925

N/A

0DataRank · unranked

75 citations

Micheala A. Aldred, Srimmitha Balachandar, Dennis Dooijes, Christina A. Eichstaedt, Stefan Gräf +71 more

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment

EBioMedicine(2025)10.1016/j.ebiom.2025.106063

N/A

0DataRank · unranked

2 citations

Jeffrey Annis, Meike Fünderich, Jochen Wilhelm, David G. Kiely, Luke Howard +71 more

Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry

Pulmonary Circulation(2025)10.1002/pul2.70121

N/A

0DataRank · unranked

3 citations

Athiththan Yogeswaran, Meike Fünderich, David G. Kiely, Andrew J. Sweatt, Roham T. Zamanian +29 more